American CryoStem Corporation
CRYO · OTC
6/30/2022 | 3/31/2022 | 12/31/2021 | 9/30/2021 | |
|---|---|---|---|---|
| Market Cap | $14 | $19 | $37 | $18 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | $15 | $20 | $39 | $19 |
| Revenue | $0 | $0 | $0 | -$0 |
| % Growth | 33.4% | -47.8% | 116.9% | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | 88.8% | 90.6% | 69.2% | 101.4% |
| EBITDA | -$0 | -$1 | -$0 | -$2 |
| % Margin | -834.7% | -2,852.2% | -555.6% | 558.4% |
| Net Income | -$0 | -$1 | -$0 | -$2 |
| % Margin | -943% | -3,018% | -622.3% | 568.5% |
| EPS Diluted | -0.009 | -0.022 | -0.007 | -0.034 |
| % Growth | 59.1% | -214.3% | 79.5% | – |
| Operating Cash Flow | -$0 | -$0 | -$1 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$1 | -$0 |